Emil Eik Nielsen

1.6k total citations
57 papers, 919 citations indexed

About

Emil Eik Nielsen is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases and Surgery. According to data from OpenAlex, Emil Eik Nielsen has authored 57 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cardiology and Cardiovascular Medicine, 7 papers in Infectious Diseases and 7 papers in Surgery. Recurrent topics in Emil Eik Nielsen's work include Atrial Fibrillation Management and Outcomes (8 papers), Heart Failure Treatment and Management (6 papers) and Cardiac, Anesthesia and Surgical Outcomes (6 papers). Emil Eik Nielsen is often cited by papers focused on Atrial Fibrillation Management and Outcomes (8 papers), Heart Failure Treatment and Management (6 papers) and Cardiac, Anesthesia and Surgical Outcomes (6 papers). Emil Eik Nielsen collaborates with scholars based in Denmark, China and United States. Emil Eik Nielsen's co-authors include Janus Christian Jakobsen, Christian Gluud, Joshua Feinberg, Sanam Safi, Naqash J Sethi, L Garby, O Lammert, Sarah Louise Klingenberg, Ronald L. Koretz and Lehana Thabane and has published in prestigious journals such as PLoS ONE, Cochrane Database of Systematic Reviews and BMJ.

In The Last Decade

Emil Eik Nielsen

55 papers receiving 885 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emil Eik Nielsen Denmark 18 211 209 175 158 153 57 919
Joshua Feinberg Denmark 15 194 0.9× 211 1.0× 159 0.9× 120 0.8× 145 0.9× 39 792
Susan Gilmour Canada 17 196 0.9× 196 0.9× 157 0.9× 313 2.0× 46 0.3× 48 1.1k
Jonathan Grotts United States 17 46 0.2× 204 1.0× 136 0.8× 109 0.7× 40 0.3× 62 778
Jonathan Roberts United States 17 145 0.7× 389 1.9× 21 0.1× 83 0.5× 119 0.8× 64 1.3k
Rahul Aggarwal United States 16 335 1.6× 136 0.7× 36 0.2× 58 0.4× 54 0.4× 57 925
Jill Vanmassenhove Belgium 16 113 0.5× 216 1.0× 30 0.2× 44 0.3× 67 0.4× 32 1.3k
Johannes Winning Germany 18 193 0.9× 393 1.9× 28 0.2× 33 0.2× 231 1.5× 39 1.1k
Jan René Nkeck Cameroon 12 169 0.8× 233 1.1× 23 0.1× 114 0.7× 250 1.6× 58 967
Ekamol Tantisattamo United States 14 129 0.6× 76 0.4× 25 0.1× 158 1.0× 99 0.6× 100 1.1k
Arin L. Madenci United States 21 284 1.3× 127 0.6× 27 0.2× 77 0.5× 155 1.0× 73 1.3k

Countries citing papers authored by Emil Eik Nielsen

Since Specialization
Citations

This map shows the geographic impact of Emil Eik Nielsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emil Eik Nielsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emil Eik Nielsen more than expected).

Fields of papers citing papers by Emil Eik Nielsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emil Eik Nielsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emil Eik Nielsen. The network helps show where Emil Eik Nielsen may publish in the future.

Co-authorship network of co-authors of Emil Eik Nielsen

This figure shows the co-authorship network connecting the top 25 collaborators of Emil Eik Nielsen. A scholar is included among the top collaborators of Emil Eik Nielsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emil Eik Nielsen. Emil Eik Nielsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nielsen, Emil Eik, et al.. (2025). Methods for drug delivery and compatibility studies in an ex vivo mucus-covered Caco-2 cell monolayer model. International Journal of Pharmaceutics. 682. 125912–125912. 1 indexed citations
3.
Adhikari, Tara Ballav, Mathias Maagaard, Reza Piri, et al.. (2024). Effect of exercise on functional capacity and body weight for people with hypertension, type 2 diabetes, or cardiovascular disease: a systematic review with meta-analysis and trial sequential analysis. BMC Sports Science Medicine and Rehabilitation. 16(1). 38–38. 3 indexed citations
4.
Nielsen, Emil Eik, Michael Hecht Olsen, Michael Kriegbaum Skjødt, et al.. (2024). A multidisciplinary, shared care clinic using personalized medicine and coordinated care in patients with concomitant type 2 diabetes and cardiovascular disease. Protocol and baseline characteristics. Preventive Medicine Reports. 38. 102594–102594. 4 indexed citations
5.
Kamp, Caroline Barkholt, Faiza Siddiqui, Joshua Feinberg, et al.. (2023). Drug interventions for prevention of COVID-19 progression to severe disease in outpatients: a systematic review with meta-analyses and trial sequential analyses (The LIVING Project). BMJ Open. 13(6). e064498–e064498. 4 indexed citations
6.
Korang, Steven Kwasi, Areti Angeliki Veroniki, Owen Ngalamika, et al.. (2022). Vaccines to prevent COVID-19: A living systematic review with Trial Sequential Analysis and network meta-analysis of randomized clinical trials. PLoS ONE. 17(1). e0260733–e0260733. 60 indexed citations
7.
Feinberg, Joshua, Michael Hecht Olsen, Axel Brandes, et al.. (2021). Lenient rate control versus strict rate control for atrial fibrillation: a protocol for the Danish Atrial Fibrillation (DanAF) randomised clinical trial. BMJ Open. 11(3). e044744–e044744. 3 indexed citations
8.
Maagaard, Mathias, Emil Eik Nielsen, Naqash J Sethi, et al.. (2021). Ivabradine added to usual care in patients with heart failure: a systematic review with meta-analysis and trial sequential analysis. BMJ evidence-based medicine. 27(4). 224–234. 5 indexed citations
9.
Juul, Sophie, Emil Eik Nielsen, Joshua Feinberg, et al.. (2021). Interventions for treatment of COVID-19: Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project). PLoS ONE. 16(3). e0248132–e0248132. 36 indexed citations
10.
Korang, Steven Kwasi, Sophie Juul, Emil Eik Nielsen, et al.. (2020). Vaccines to prevent COVID-19: a protocol for a living systematic review with network meta-analysis including individual patient data (The LIVING VACCINE Project). Systematic Reviews. 9(1). 262–262. 28 indexed citations
11.
Nørskov, Anders Kehlet, Theis Lange, Emil Eik Nielsen, et al.. (2020). Assessment of assumptions of statistical analysis methods in randomised clinical trials: the what and how. BMJ evidence-based medicine. 26(3). 121–126. 23 indexed citations
14.
Maagaard, Mathias, Emil Eik Nielsen, Christian Gluud, & Janus Christian Jakobsen. (2019). Ivabradine for coronary artery disease and/or heart failure—a protocol for a systematic review of randomised clinical trials with meta-analysis and Trial Sequential Analysis. Systematic Reviews. 8(1). 39–39. 4 indexed citations
15.
Jakobsen, Janus Christian, Emil Eik Nielsen, Ronald L. Koretz, & Christian Gluud. (2018). Do direct acting antivirals cure chronic hepatitis C?. BMJ. 361. k1382–k1382. 27 indexed citations
18.
Sethi, Naqash J, Joshua Feinberg, Emil Eik Nielsen, et al.. (2017). The effects of rhythm control strategies versus rate control strategies for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and Trial Sequential Analysis. PLoS ONE. 12(10). e0186856–e0186856. 49 indexed citations
19.
Feinberg, Joshua, Emil Eik Nielsen, & Janus Christian Jakobsen. (2017). Thrombolysis for acute upper extremity deep vein thrombosis. Cochrane Database of Systematic Reviews. 2017(12). CD012175–CD012175. 18 indexed citations
20.
Forsén, Björn, et al.. (1987). Felodipine versus Hydrochlorothiazide as an Addition to a β-Blocker in the Treatment of Hypertension. Drugs. 34(Supplement 3). 136–138. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026